Provision and financing of assistive technology devices in Germany: A bureaucratic odyssey? The case of amyotrophic lateral sclerosis and Duchenne muscular dystrophy
Author
Abstract
Suggested Citation
DOI: 10.1016/j.healthpol.2012.01.013
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
References listed on IDEAS
- Reinhard Busse & Tom Stargardt & Jonas Schreyögg, 2005. "Determining the “Health Benefit Basket” of the Statutory Health Insurance scheme in Germany," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 6(1), pages 30-36, November.
- Schreyögg, Jonas & Bäumler, Michael & Busse, Reinhard, 2009. "Balancing adoption and affordability of medical devices in Europe," Health Policy, Elsevier, vol. 92(2-3), pages 218-224, October.
Citations
Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
Cited by:
- Alina Pishnyak & Aleksandra Goriainova & Elena Tochilina, 2017. "The Determinants of the Development of the Russian Assistive Technologies Market in the Context of the Interaction of Various Groups of Agents," HSE Working papers WP BRP 12/PSP/2017, National Research University Higher School of Economics.
- Jun Suzurikawa & Yuki Sawada & Miwa Sakiyama & Motoi Suwa & Takenobu Inoue & Tomoko Kondo, 2021. "Perspectives of Multidisciplinary Professional Teams during Assessment Processes for ATD Selection in the Japanese Public Provision System," IJERPH, MDPI, vol. 18(5), pages 1-16, March.
- Katarina Baudin & Maria Mullersdorf & Angelina Sundstrom & Christine Gustafsson, 2020. "The Policies of Provision of Assistive and Welfare Technology—A Literature Review," Societies, MDPI, vol. 10(1), pages 1-16, February.
- Fischer, Julia & Van de Bovenkamp, Hester M., 2019. "The challenge of democratic patient representation: Understanding the representation work of patient organizations through methodological triangulation," Health Policy, Elsevier, vol. 123(1), pages 109-114.
- Juyeon Oh & Jung A Kim, 2017. "Supportive care needs of patients with amyotrophic lateral sclerosis/motor neuron disease and their caregivers: A scoping review," Journal of Clinical Nursing, John Wiley & Sons, vol. 26(23-24), pages 4129-4152, December.
- Kleinhout-Vliek, Tineke & de Bont, Antoinette & Boer, Bert, 2017. "The bare necessities? A realist review of necessity argumentations used in health care coverage decisions," Health Policy, Elsevier, vol. 121(7), pages 731-744.
Most related items
These are the items that most often cite the same works as this one and are cited by the same works as this one.- Olberg, Britta & Perleth, Matthias & Busse, Reinhard, 2014. "The new regulation to investigate potentially beneficial diagnostic and therapeutic methods in Germany: Up to international standard?," Health Policy, Elsevier, vol. 117(2), pages 135-145.
- Rachet-Jacquet, Laurie & Toulemon, Léa & Rochaix, Lise, 2021.
"Hospital payment schemes and high-priced drugs: Evidence from the French Add-on List,"
Health Policy, Elsevier, vol. 125(7), pages 923-929.
- Laurie Rachet-Jacquet & Léa Toulemon & Lise Rochaix, 2021. "Hospital payment schemes and high-priced drugs: Evidence from the French Add-on List," PSE-Ecole d'économie de Paris (Postprint) halshs-03238834, HAL.
- Laurie Rachet-Jacquet & Léa Toulemon & Lise Rochaix, 2021. "Hospital payment schemes and high-priced drugs: Evidence from the French Add-on List," Post-Print halshs-03238834, HAL.
- Laurie Rachet-Jacquet & Léa Toulemon & Lise Rochaix, 2021. "Hospital payment schemes and high-priced drugs: Evidence from the French Add-on List," Institut des Politiques Publiques halshs-03238834, HAL.
- Sorenson, Corinna & Kanavos, Panos, 2011. "Medical technology procurement in Europe: A cross-country comparison of current practice and policy," Health Policy, Elsevier, vol. 100(1), pages 43-50, April.
- Zippel, Claus & Bohnet-Joschko, Sabine, 2017. "Post market surveillance in the german medical device sector – current state and future perspectives," Health Policy, Elsevier, vol. 121(8), pages 880-886.
- Martelli, Nicolas & van den Brink, Hélène, 2014. "Special funding schemes for innovative medical devices in French hospitals: The pros and cons of two different approaches," Health Policy, Elsevier, vol. 117(1), pages 1-5.
- Maximilian H. M. Hatz & Jonas Schreyögg & Aleksandra Torbica & Giuseppe Boriani & Carl R. B. Blankart, 2017. "Adoption Decisions for Medical Devices in the Field of Cardiology: Results from a European Survey," Health Economics, John Wiley & Sons, Ltd., vol. 26(S1), pages 124-144, February.
- J. Schreyögg & T. Stargardt & M. Velasco-Garrido & R. Busse, 2005. "Defining the “Health Benefit Basket” in nine European countries," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 6(1), pages 2-10, November.
- Fischer, Katharina E. & Rogowski, Wolf H. & Leidl, Reiner & Stollenwerk, Björn, 2013. "Transparency vs. closed-door policy: Do process characteristics have an impact on the outcomes of coverage decisions? A statistical analysis," Health Policy, Elsevier, vol. 112(3), pages 187-196.
- Kastanioti, Catherine & Kontodimopoulos, Nick & Stasinopoulos, Dionysis & Kapetaneas, Nikolaos & Polyzos, Nikolaos, 2013. "Public procurement of health technologies in Greece in an era of economic crisis," Health Policy, Elsevier, vol. 109(1), pages 7-13.
- Franz Tödtling & Tanja Sinozic & Alexander Auer, 2016.
"Knowledge bases, multi-scale interaction and transformation of the Vienna medical cluster,"
SRE-Disc
sre-disc-2016_03, Institute for Multilevel Governance and Development, Department of Socioeconomics, Vienna University of Economics and Business.
- Tödtling, Franz & Sinozic, Tanja & Auer, Alexander, 2016. "Knowledge bases, multi-scale interaction and transformation of the Vienna medical cluster," SRE-Discussion Papers 2016/03, WU Vienna University of Economics and Business.
- Amitabh Chandra & Jonathan S. Skinner, 2011. "Technology Growth and Expenditure Growth in Health Care," NBER Working Papers 16953, National Bureau of Economic Research, Inc.
- Levaggi, Rosella & Moretto, Michele & Pertile, Paolo, 2014. "Two-part payments for the reimbursement of investments in health technologies," Health Policy, Elsevier, vol. 115(2), pages 230-236.
- Gallego, Gisselle & Casey, Robert & Norman, Richard & Goodall, Stephen, 2011. "Introduction and uptake of new medical technologies in the Australian health care system: A qualitative study," Health Policy, Elsevier, vol. 102(2), pages 152-158.
- Joyce Craig & Louise Carr & John Hutton & Julie Glanville & Cynthia Iglesias & Andrew Sims, 2015. "A Review of the Economic Tools for Assessing New Medical Devices," Applied Health Economics and Health Policy, Springer, vol. 13(1), pages 15-27, February.
- Rosanna Tarricone & Aleksandra Torbica & Michael Drummond, 2017. "Challenges in the Assessment of Medical Devices: The MedtecHTA Project," Health Economics, John Wiley & Sons, Ltd., vol. 26(S1), pages 5-12, February.
- Giuditta Callea & Aleksandra Torbica & Rosanna Tarricone, 2014. "Impatto del sistema di finanziamento a DRG sull?innovazione tecnologica in sanit?. Il caso italiano," MECOSAN, FrancoAngeli Editore, vol. 2014(89), pages 31-48.
- Peckham, Allie & Miller, Fiona A. & Marchildon, Gregory P., 2021. "Comparison of outpatient coverage in Canada: Assistive and medical devices," Health Policy, Elsevier, vol. 125(12), pages 1536-1542.
- Fourie, Carina & Biller-Andorno, Nikola & Wild, Verina, 2014. "Systematically evaluating the impact of diagnosis-related groups (DRGs) on health care delivery: A matrix of ethical implications," Health Policy, Elsevier, vol. 115(2), pages 157-164.
- Florian Hofer & Dmitrij Achelrod & Tom Stargardt, 2016. "Cost-Utility Analysis of Telemonitoring Interventions for Patients with Chronic Obstructive Pulmonary Disease (COPD) in Germany," Applied Health Economics and Health Policy, Springer, vol. 14(6), pages 691-701, December.
- Deo, Sarang & Tyagi, Hanu & Chatterjee, Chirantan & Molakapuri, Himasagar, 2020. "Did India's price control policy for coronary stents create unintended consequences?," Social Science & Medicine, Elsevier, vol. 246(C).
More about this item
Keywords
Assistive technology devices; Duchenne muscular dystrophy; Amyotrophic lateral sclerosis; Financing; Qualitative study; Germany;All these keywords.
Statistics
Access and download statisticsCorrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:eee:hepoli:v:105:y:2012:i:2:p:176-184. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Catherine Liu or the person in charge (email available below). General contact details of provider: http://www.elsevier.com/locate/healthpol .
Please note that corrections may take a couple of weeks to filter through the various RePEc services.